Sino Biopharmaceutical Limited: Hepatitis B, Chronic trials

The registry lists 13 Hepatitis B, Chronic studies with Sino Biopharmaceutical Limited as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 6Phase 3 1Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseNot yet recruitingNCT07797231Phase 3
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis BRecruitingNCT06566248Phase 2
• A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis BNot yet recruitingNCT06452693Phase 1/2
• A Clinical Trial of TQA3038 Injection in Healthy Adult SubjectsRecruitingNCT06085053Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected SubjectsWithdrawnNCT06990776Phase 2
• Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV InfectionActive, not recruitingNCT06706310Phase 2
• Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 TabletsCompletedNCT06431438Phase 1
• A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis BActive, not recruitingNCT06150014Phase 1/2
• A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis BStatus unknownNCT04180150Phase 2
• Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy VolunteersCompletedNCT03847246Not applicable
• Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
• Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
• Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4